- Home
- FMST vs RNXT Comparison
FMST vs RNXT Comparison
Compare FMST & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMST
- RNXT
- Stock Information
- Founded
- FMST 2005
- RNXT 2012
- Country
- FMST Canada
- RNXT United States
- Employees
- FMST N/A
- RNXT N/A
- Industry
- FMST Other Metals and Minerals
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- FMST Basic Materials
- RNXT Health Care
- Exchange
- FMST Nasdaq
- RNXT Nasdaq
- Market Cap
- FMST 38.2M
- RNXT 44.6M
- IPO Year
- FMST N/A
- RNXT 2021
- Fundamental
- Price
- FMST $2.92
- RNXT $1.28
- Analyst Decision
- FMST
- RNXT Strong Buy
- Analyst Count
- FMST 0
- RNXT 2
- Target Price
- FMST N/A
- RNXT $7.50
- AVG Volume (30 Days)
- FMST 441.0K
- RNXT 594.5K
- Earning Date
- FMST 08-13-2025
- RNXT 11-12-2025
- Dividend Yield
- FMST N/A
- RNXT N/A
- EPS Growth
- FMST N/A
- RNXT N/A
- EPS
- FMST N/A
- RNXT N/A
- Revenue
- FMST N/A
- RNXT $662,000.00
- Revenue This Year
- FMST N/A
- RNXT $2,988.37
- Revenue Next Year
- FMST N/A
- RNXT $300.60
- P/E Ratio
- FMST N/A
- RNXT N/A
- Revenue Growth
- FMST N/A
- RNXT N/A
- 52 Week Low
- FMST $0.55
- RNXT $0.75
- 52 Week High
- FMST $5.74
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- FMST 47.43
- RNXT 61.50
- Support Level
- FMST $2.96
- RNXT $1.06
- Resistance Level
- FMST $3.24
- RNXT $1.27
- Average True Range (ATR)
- FMST 0.25
- RNXT 0.10
- MACD
- FMST -0.03
- RNXT 0.04
- Stochastic Oscillator
- FMST 14.12
- RNXT 69.64
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.